Procter & Gamble earnings beat estimates, but weak demand in China hurts sales

Job creation eased more than expected in December while wages grew at the slowest pace in nearly 3½ years.

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes. 

This company is a leader in a growing market, per Goldman.